Items tagged with Drug-resistant TB
WHO maintains existing recommendations for the use of bedaquiline (post with simple image)
The conditional recommendation will be maintained until a new systematic review of evidence is warranted or the results of the phase III clinical trial of bedaquiline become available.
Advocates encourage the health authorities in Peru to approve the endTB study (post with simple image)
TB advocates stress the importance of the observational endTB study for expanding access to new treatments for multidrug-resistant TB in Peru.
Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval (post with simple image)
Companies and countries must take urgent action to increase access to these life-saving treatments.
World TB Day 2017: The Lancet Respiratory Medicine: special issue on TB (post with simple image)
Advocates call on Otsuka to ensure access to delamanid in South Africa (post with simple image)
TB advocates urge Otsuka to provide sufficient and sustainable access to delamanid for the treatment of drug-resistant TB in South Africa.
EU leaders seek new tools against drug-resistant TB (post with simple image)
EU leaders urge funding for new treatment and prevention tools against drug-resistant TB.
We had to run our own trial for TB drugs – nobody else was doing it (post with simple image)
Tuberculosis kills more people than HIV, but medicines to treat the disease have barely improved in 50 years - it’s time for urgent and radical innovation.
WHO updates Essential Medicines List (post with simple image)
WHO updates Essential Medicines List with new advice on use of antibiotics and adds medicines for TB.
Community response to the drug-resistant TB crisis in Europe (post with simple image)
Video summary report from a series of meetings on drug-resistant TB held in May 2017.
TB CAB's proposed development pathway for regimens to treat XDR-TB (post with simple image)
Тhe Global TB Community Advisory Board (TB CAB) releases a position paper regarding the optimal design for future evaluation of regimens for the treatment of extensively drug-resistant TB (XDR-TB).
Page 71 of 73 · Total posts: 0←First 70 71 72 Last→